Despite weight loss and glycemic control, experts caution that type 2 diabetes remission is not a cure and that pancreatic ...

The best-selling author and podcaster on how to preserve robust physical, cognitive and emotional health, and how Medicine ...

SGLT2 inhibitor use was not associated with an increased risk for postoperative diabetic ketoacidosis among patients with type 2 diabetes.

At the foundation of healthspan medicine are the pillars of health. These are easily understood through four simple verbs: ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...

Are you ignoring the early signs of kidney disease in diabetes? As diabetic kidney disease is on the rise, here’s what ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors have emerged as a revolutionary class of drugs in managing both diabetes and CKD. SGLT2 inhibitors, such as empagliflozin, dapagliflozin ...

Individuals using a GLP-1 agent, SGLT2 inhibitor, or both at baseline also had greater reductions in HbA1c with AID use. An automated insulin delivery (AID) system boosted glycemic control in ...

Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of ...

The much-awaited launch of Mounjaro, an injectable drug used to treat obesity, overweight, and type 2 diabetes, has been ...

USV launches empagliflozin and its combinations for diabetes care in India: Our Bureau, Bengaluru Wednesday, March 19, 2025, 12:40 Hrs [IST] USV, an Indian multinational healthcar ...